- Home
- PROK vs ATEX Comparison
PROK vs ATEX Comparison
Compare PROK & ATEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- ATEX
- Stock Information
- Founded
- PROK 2015
- ATEX 1997
- Country
- PROK United States
- ATEX United States
- Employees
- PROK N/A
- ATEX N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- ATEX Telecommunications Equipment
- Sector
- PROK Health Care
- ATEX Telecommunications
- Exchange
- PROK Nasdaq
- ATEX Nasdaq
- Market Cap
- PROK 417.1M
- ATEX 381.9M
- IPO Year
- PROK N/A
- ATEX N/A
- Fundamental
- Price
- PROK $2.78
- ATEX $18.01
- Analyst Decision
- PROK Strong Buy
- ATEX Buy
- Analyst Count
- PROK 4
- ATEX 2
- Target Price
- PROK $6.25
- ATEX $58.50
- AVG Volume (30 Days)
- PROK 1.5M
- ATEX 176.3K
- Earning Date
- PROK 11-10-2025
- ATEX 11-12-2025
- Dividend Yield
- PROK N/A
- ATEX N/A
- EPS Growth
- PROK N/A
- ATEX N/A
- EPS
- PROK N/A
- ATEX 1.58
- Revenue
- PROK $744,000.00
- ATEX $5,924,000.00
- Revenue This Year
- PROK $471.74
- ATEX N/A
- Revenue Next Year
- PROK N/A
- ATEX $5.18
- P/E Ratio
- PROK N/A
- ATEX $11.41
- Revenue Growth
- PROK N/A
- ATEX 15.97
- 52 Week Low
- PROK $0.46
- ATEX $17.58
- 52 Week High
- PROK $7.13
- ATEX $42.91
- Technical
- Relative Strength Index (RSI)
- PROK 45.61
- ATEX 32.08
- Support Level
- PROK $2.56
- ATEX $17.58
- Resistance Level
- PROK $2.94
- ATEX $18.55
- Average True Range (ATR)
- PROK 0.23
- ATEX 0.73
- MACD
- PROK -0.05
- ATEX -0.14
- Stochastic Oscillator
- PROK 25.41
- ATEX 14.72
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About ATEX Anterix Inc.
Anterix Inc is a United States-based company engaged in delivering broadband needed to modernize infrastructure for energy, transportation, logistics, and other industries. The company offers Private LTE for utilities which help to automate processes, monitor environmental conditions, enable artificial intelligence, and drive productivity.